Risk factors

Mesa Laboratories (MLAB) risk factors

Item 1A of every Mesa Laboratories Inc. 10-K on file, and what changed from one year to the next.

Open MLAB in Gloomberb →
  • FY2026 10-K risk factors

    49 risks, 12 new, 11 dropped, 37 reworded since the prior year. New risks focus on supply-chain disruption, tariffs, FDA and cybersecurity compliance, and the March 2026 CEO transition.

    Filed Jun 03, 2026
  • FY2025 10-K risk factors

    48 risks. Mesa Laboratories faces intense market competition, strict FDA and international regulatory requirements, and integration risks from strategic business acquisitions. Significant revenue concentration relies on key customers, distributors, and specific product lines like Dialyguard.

    Filed May 28, 2025